We are rarely re-posting articles but… no way to say better that Pros do: Silimed: Particles and Polymers – Professor J D Frame, Dr M Olivan The recent release of censured but commercially sensitive information on particle surface contamination of silicone implants via the Silimed information centre , the MHRA (Medicines and Healthcare Regulatory Agency), […]
Congratulations to everyone who’s followed our alert on SIEN Up to 15% in a matter of a few days – can you find a better trade from an entire Nasdaq? SIEN – we re-enter into at mid-day on Friday for a “hold” for a month or a few. Good reading: Sientra sends letter to surgeons […]
SIEN: see you at chart reversal News: SANTA BARBARA, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that the Company will host an investor and analyst update conference call on Wednesday October 28, 2015 at 4:15 p.m. ET/1:15 p.m. PT. The dial-in numbers are (844) 464-3933 for […]
Is anyone wonder what would required from Sientra to re-open production in a new manufacturing facility? Sec. 814.39 PMA supplements. (a) After FDA’s approval of a PMA, an applicant shall submit a PMA supplement for review and approval by FDA before making a change affecting the safety or effectiveness of the device for which the […]
Sientra Inc. expected to be the queen of the breast-implant industry when it entered the U.S. market in 2012 with set of new shapes and textures – so much for women to choose from. Said so, the company was supplying about 9-10 percent of implants in the U.S., a.k.a. took roughly $30 million of $300 million […]
Rare Element Resources (REE) shares gained 20.86% on Friday’s trading session closed a few cents off of its monthly resistance within 4X 3month volume average: Classical chart setup, isn’t it? Rare Element Resources Ltd. is a mineral resource company focused on exploration and development of rare earth deposits, specifically those with significant distribution of critical […]
GlassesOff (GLSO) could revolutionize how presbyopia is treated, all for 15 minutes a day, 3 days a week, for 2 – 3 months at most. Decades of research into neuroplasticity underlie a robust program that is developed as a ‘game’ that ‘trains’ your brain to better process near objects and images. GLSO recently announced the […]
We sent email to our subscribers on August 29th with our new break-out pick: Advaxis (ADXS). Congratulations to all who followed our alert – ADXS‘s share price doubled in less than 2 weeks! Email: ADXS Breaks Resistance and Set To Rally Advaxis made a strong move on Thursday, despite the typical quiet week of trading before […]
Antriabio – which trades under the ticker “ANTB” – is about to bounce. If you’ve been following what I have to say I also think ANTB has 10-bagger potential (more about that in a moment). According to otcshortreport.com, about 50% of the shares that have traded in the last 30 days were sold short. A […]
ARCA Biopharma (ABIO) has been alerted as day-trading investment opportunity in real-time to our Twitter & Facebook followers at an around $.50/share. ABIO stock closed at $.68/share for the solid 36% in day-trading gains. Yesterday ABIO announced an update on a proposed, genetically-targeted clinical trial in atrial fibrillation (“AF”) of the Company’s lead developmental drug, Gencaro […]
